HIV breakthrough trial seeks to rescue failing treatments in africa
NCT ID NCT05373758
First seen Mar 30, 2026 · Last updated May 29, 2026 · Updated 3 times
Summary
This study tests different approaches to help people with HIV whose current medication (tenofovir, lamivudine, and dolutegravir, or TLD) is no longer working. It involves 648 adults and teens in Uganda and South Africa. The goal is to find the best strategy to get the virus under control again, measured by a very low viral load after 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mbarara City Clinic
RECRUITINGMbarara, Uganda
Contact
Contact
-
Mbarara Regional Referral Hospital Immune Suppression Syndrome Clinic
RECRUITINGMbarara, Uganda
Contact
Contact
-
RK Khan Hospital Clinic
RECRUITINGDurban, South Africa
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.